Dr Melvin Teck Meng Chin
Senior Lecturer

Dr Melvin Teck Meng Chin

BSc(Med) MB BS, MHM, AFCHSM, FRACP

Medicine & Health
POW Clinical School Operating

Melvin Chin is a clinical academic medical oncologist – he cares for patients with lung, melanoma, gastrointestinal and other cancers and he teaches UNSW medical students in the Oncology and Palliative Care term. He was the Head of Department-Medical Oncology at the Prince of Wales Hospital from 2015-2018 overseeing the move of clinical services into the Nelune Comprehensive Cancer Centre and the seemless collaboration with the Scientia Clinical Research. He is a member of the South Eastern Sydney Local Health District Human Research Ethics Committee. He has contributed to numerous clinical trials and health services research studies and continues to nurture new research collaborations. 

Publications

  • Journal articles | 2021
    Dr Melvin Teck Meng Chin
    Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, vol. 31, http://dx.doi.org/10.17061/PHRP31122108
    Journal articles | 2021
    Dr Melvin Teck Meng Chin
    McLean LS; Faisal W; Parakh S; Kao SC; Lewis CR; Chin MT; Voskoboynik M; Itchins MJ; Jennens RR; Broad AR; Morris TA; Solomon BJ, 2021, 'Standard-Dose Osimertinib in EGFR-Mutated Non–Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease', JCO Precision Oncology, pp. 561 - 568, http://dx.doi.org/10.1200/po.20.00464
    Journal articles | 2020
    Dr Melvin Teck Meng Chin
    Ali A; Dumbrava M; Riddell K; Stewart N; Ward R; Ibrahim AK; Chin M, 2020, 'Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial', BMC Cancer, vol. 20, pp. 342, http://dx.doi.org/10.1186/s12885-020-06848-8
    Journal articles | 2020
    Dr Melvin Teck Meng Chin
    Vuong K; Uebel K; Agaliotis M; Jun S; Taggart J; Suchy S; Liauw W; Chin M; Webber K; Harris M, 2020, 'Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study', BMC Family Practice, vol. 21, http://dx.doi.org/10.1186/s12875-020-01311-w
    Journal articles | 2019
    Dr Melvin Teck Meng Chin
    Lam W; Nowak A; Chen F; Muruganandan S; Arunachalam S; Chin M; Millward M; Read C; Murray K; Creaney J; Lee YCG, 2019, 'MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study', Journal of Thoracic Oncology, vol. 14, pp. S342 - S342, http://dx.doi.org/10.1016/j.jtho.2019.08.691
    Journal articles | 2019
    Dr Melvin Teck Meng Chin
    Lamprell K; Chin M; Braithwaite J, 2019, '“Can I still get a tattoo?” Patients’ experiences across the clinical trajectory for metastatic melanoma: a dynamic narrative model of patient journey', Patient Experience Journal, vol. 6, pp. 87 - 93, http://dx.doi.org/10.35680/2372-0247.1301
    Journal articles | 2018
    Dr Melvin Teck Meng Chin
    Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N, 2018, 'Using behaviour change and implementation science to address low referral rates in oncology 11 Medical and Health Sciences 1117 Public Health and Health Services', BMC Health Services Research, vol. 18, pp. 904, http://dx.doi.org/10.1186/s12913-018-3653-1
    Journal articles | 2018
    Dr Melvin Teck Meng Chin
    Lamprell K; Chin M; Braithwaite J, 2018, 'The plot thickens: Archetypal narrative structure in the melanoma patient journey', Cogent Medicine, vol. 5, pp. 1484053 - 1484053, http://dx.doi.org/10.1080/2331205x.2018.1484053
    Journal articles | 2017
    Dr Melvin Teck Meng Chin
    Schütze H; Chin M; Weller D; Harris MF, 2017, 'Patient, general practitioner and oncologist views regarding long-term cancer shared care.', Fam Pract, vol. 35, pp. 323 - 329, http://dx.doi.org/10.1093/fampra/cmx105
    Journal articles | 2017
    Dr Melvin Teck Meng Chin
    Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, vol. 54, pp. 74 - 84, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015
    Journal articles | 2017
    Dr Melvin Teck Meng Chin
    Pianta TJ; Pickering JW; Succar L; Chin M; Davidson T; Buckley NA; Mohamed F; Endre ZH, 2017, 'Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy', Kidney and Blood Pressure Research, vol. 42, pp. 62 - 75, http://dx.doi.org/10.1159/000469715
    Journal articles | 2017
    Dr Melvin Teck Meng Chin
    Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R, 2017, 'Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study', European Journal of Cancer Care, vol. 26, http://dx.doi.org/10.1111/ecc.12600
    Journal articles | 2016
    Dr Melvin Teck Meng Chin
    Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M, 2016, 'Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: A study protocol', BMC Health Services Research, vol. 16, http://dx.doi.org/10.1186/s12913-016-1331-8
    Journal articles | 2016
    Dr Melvin Teck Meng Chin
    He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530
    Journal articles | 2016
    Dr Melvin Teck Meng Chin
    Bloem LT; De Abreu Lourenço R; Chin M; Ly B; Haas M, 2016, 'Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer', Oncology and Therapy, vol. 4, pp. 103 - 116, http://dx.doi.org/10.1007/s40487-016-0020-4
    Journal articles | 2016
    Dr Melvin Teck Meng Chin
    Lemech CR; Williams R; Thompson SR; McCaughan B; Chin M, 2016, 'Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: A case report', BMC Research Notes, vol. 9, http://dx.doi.org/10.1186/s13104-016-2189-x
    Journal articles | 2016
    Dr Melvin Teck Meng Chin
    Au L; Grant M; Haydon A; Oliva K; Wilkins S; Segelov E; Antill Y; Peter C; Ranchod P; Polglase A; Chin M; Chip F; Skinner S; Roger W; McMurrick P; Shapiro J, 2016, '198P Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer', Annals of Oncology, vol. 27, http://dx.doi.org/10.1093/annonc/mdw581.031
    Journal articles | 2015
    Dr Melvin Teck Meng Chin
    Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, vol. 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571
    Journal articles | 2014
    Dr Melvin Teck Meng Chin
    Falchook GS; Long GV; Kurzrock R; Kim KB; Arkenau HT; Brown MP; Hamid O; Infante JR; Millward M; Pavlick A; Chin MT; O'Day SJ; Blackman SC; Martin C; Lebowitz P; Ma B; Ouellet D; Kefford RF, 2014, 'Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)', Clinical Cancer Research, vol. 20, pp. 4449 - 4458, http://dx.doi.org/10.1158/1078-0432.CCR-14-0887
    Journal articles | 2014
    Dr Melvin Teck Meng Chin
    Mak G; Arkenau HT; Chin M, 2014, 'Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment', Melanoma Research, vol. 24, pp. 408 - 412, http://dx.doi.org/10.1097/CMR.0000000000000085
    Journal articles | 2014
    Dr Melvin Teck Meng Chin
    Mak G; Chin M; Nahar N; De Souza P, 2014, 'Cutaneous metastasis of prostate carcinoma treated with radiotherapy: A case presentation', BMC Research Notes, vol. 7, http://dx.doi.org/10.1186/1756-0500-7-505
    Journal articles | 2014
    Dr Melvin Teck Meng Chin
    Chin M; Ward RL, 2014, 'Targeting treatment for colorectal cancer: The EGFR antibody story', Cancer Forum, vol. 38, pp. 39 - 43
    Journal articles | 2013
    Dr Melvin Teck Meng Chin
    Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori Journal, vol. 99, pp. e225 - e228, http://dx.doi.org/10.1177/030089161309900518
    Journal articles | 2013
    Dr Melvin Teck Meng Chin
    Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori, vol. 99, http://dx.doi.org/10.1700/1377.15320
    Journal articles | 2013
    Dr Melvin Teck Meng Chin
    Pianta T; Chin M; Peake P; Buckley N; Pickering J; Endre Z, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', NEPHROLOGY, vol. 18, pp. 41 - 41, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Dr Melvin Teck Meng Chin
    Lemech CR; Fontela A; Arkenau H-T; Chin MTM; Li S; Liauw WS; Thomas D; De Souza PL, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours.', Journal of Clinical Oncology, vol. 30, pp. e13585 - e13585, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13585
    Journal articles | 2010
    Dr Melvin Teck Meng Chin
    Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, vol. 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8
    Journal articles | 2010
    Dr Melvin Teck Meng Chin
    Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, vol. 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8
    Journal articles | 2010
    Dr Melvin Teck Meng Chin
    Pearson S; Chin M; Faedo M; Ward RL, 2010, 'Rationale for treatment durations of targeted cancer agents', Lancet Oncology, vol. 11, pp. 1113 - 1115, http://dx.doi.org/10.1016/S1470-2045(10
    Journal articles | 2006
    Dr Melvin Teck Meng Chin
    Grimison PS; T Chin M; Harrison ML; Goldstein D, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-117
    Journal articles | 1998
    Dr Melvin Teck Meng Chin
    Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS; McBride M; Chin MTM; Lee SM; Kelly B, 1998, 'Lipid lowering therapy in patients with HIV infection (multiple letters) [3]', Lancet, vol. 352, pp. 1782 - 1783, http://dx.doi.org/10.1016/s0140-6736(05)79858-5
  • Reports | 2018
    Dr Melvin Teck Meng Chin
    Taggart J; Harris MF; Chin M, 2018, Cancer Shared eCare Plan Information Requirements and Care Plan Templates Jan 2018
  • Conference Posters | 2020
    Dr Melvin Teck Meng Chin
    Abdelmogod A; Robinson L; Coleman L; Chah K; Chin M; O'Neill S, 2020, 'Retrospective analysis of chemotherapy‐induced febrile neutropenia; Local experience towards risk‐based management', Virtual, Vol. 16, pp. 142 - 142, presented at Clinical Oncology Society Australia Annual Scientific Meeting, Virtual, 11 November 2020 - 13 November 2020, http://dx.doi.org/10.1111/ajco.13498
    Conference Posters | 2020
    Dr Melvin Teck Meng Chin
    Bailey S; Ehrlich R; Lapin D; Chin M, 2020, 'Clinical audit of chest drain complications in medical oncology patients', Virtual, Vol. 16, pp. 142 - 143, presented at Clinical Oncology Society Australia Annual Scientific Meeting 2020, Virtual, 11 November 2020 - 13 November 2020, http://dx.doi.org/10.1111/ajco.13498
    Conference Abstracts | 2019
    Dr Melvin Teck Meng Chin
    Foong M; Botes L; Shum M; Schipp D; Porwal M; Barat S; Chin M, 2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 212 - 213, presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Adelaide Convention Centre, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
    Conference Presentations | 2019
    Dr Melvin Teck Meng Chin
    Chin M; Harris M; Taggart J; Liauw W, 2019, 'Sharing the care of patients with cancer between specialists and general practitioners', presented at Australasian College of Health Service Management, Gold Coast Convention Centre, 09 October 2019 - 11 October 2019
    Conference Abstracts | 2019
    Dr Melvin Teck Meng Chin
    Chah KT; Chin M; Siu HW; Brell N, 2019, 'A retrospective audit of male prisoners referred to Cancer Services at Prince of Wales Hospital', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 134 - 134, presented at Clinical Oncology Society of Australia, Adelaide Convention Centre, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
    Conference Abstracts | 2019
    Dr Melvin Teck Meng Chin
    Foong M; Botes LP; Porwal M; Barat S; Shum M; Schipp D; Chin M, 2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 104 - 105, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dr Melvin Teck Meng Chin
    Vaughan BK; Rossleigh M; Parasyn A; Chin M, 2018, 'The Ability of BRAF Therapy to Convert an Iodine Negative to Iodine Positive Thyroid Cancer Patient', in World Journal of Nuclear Medicine, Medknow Publications, Melbourne, Vol. 17, pp. 49 - 342, presented at 12th Congress of the World Federation of Nuclear Medicine and Biology, Melbourne, 20 April 2018 - 24 April 2018, http://www.wjnm.org/text.asp?2018/17/5/49/241904
    Conference Posters | 2017
    Dr Melvin Teck Meng Chin
    Williams R; Long J; Debono D; Chin MT; Taylor N, 2017, 'WORKING WITH CLINICIANS TO IDENTIFY BARRIERS TO FAMILY CANCER CLINIC REFERRALS FOR PATIENTS AT HIGH RISK OF LYNCH SYNDROME', Florence, presented at InSIGHT 7th Biennial Meeting, Florence, 05 July 2017 - 08 July 2017, http://www.2017insight.com/
    Conference Papers | 2017
    Dr Melvin Teck Meng Chin
    Chin TTC; Botes LLB; Chin MMC, 2017, 'Compassionate Supply of Oncology Drugs Within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 188 - 188, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500311&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2016
    Dr Melvin Teck Meng Chin
    Harris M; Schutze H; Chin MT; Weller D; Suchy S, 2016, 'Patient, specialist and GP perspectives on sharing cancer care: It takes at least three to tango', presented at 2016 Primary Health Care Research Conference, National Convention Centre, Canberra, 08 June 2016 - 09 June 2016, http://www.phcris.org.au/roar/profiles/featured-activity.php?id=18599#all
    Other | 2016
    Dr Melvin Teck Meng Chin
    Pal A (ed.), 2016, Between Cure and Palliation, onthewards, https://onthewards.org/between-cure-and-palliation/
    Conference Abstracts | 2015
    Dr Melvin Teck Meng Chin
    Taylor N; Williams R; Debono D; Chin M; Long J; Salisbury E; Butler J; Potter M; O'Neill S; Braithwaite J, (ed.), 2015, 'ACHIEVING HEALTHCARE PROFESSIONAL BEHAVIOUR CHANGE FOR DETECTION AND MANAGEMENT OF LYNCH SYNDROME', in ACHIEVING HEALTHCARE PROFESSIONAL BEHAVIOUR CHANGE FOR DETECTION AND MANAGEMENT OF LYNCH SYNDROME, Wiley Online Library, Hobart, Tasmania, Australia, Vol. 11, pp. 102 - 103, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Hobart, Tasmania, Australia, 17 November 2015 - 19 November 2015, http://dx.doi.org/10.1111/ajco.12432_2
    Conference Abstracts | 2015
    Dr Melvin Teck Meng Chin
    Liang R; Meiser B; Smith S; Kasparian N; Lewis C; Chin M; Long G; Ward R; Menzies A; Gumniski A; Harris J; Kaur R, 2015, 'Oncology patients’ attitudes toward, and experiences with, somatic mutation tumour testing', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Tasmania, Australia, Vol. 11, pp. 144 - 144, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Tasmania, Australia, 17 December 2015 - 19 November 2015, http://dx.doi.org/10.1111/ajco.12432_2
    Conference Presentations | 2015
    Dr Melvin Teck Meng Chin
    Debono D; Taylor N; Long J; Braithwaite J; Chin MT; Williams R; Salisbury E; O'Neill S; Dunlop T; Phan-Tien K; Eykman E, 2015, 'Referral as imagined versus referral as done: mapping the referral process for genetic counselling for Lynch syndrome patients', presented at 2015 Innovations in Cancer Treatment and Care Conference, Aerial UTS Function Centre, Sydney, 15 October 2015 - 15 October 2015, https://www.cancerinstitute.org.au/about-us/events/innovations-in-cancer-treatment-and-care/Past-conferences/Abstracts/referral-as-imagined-versus-referral-as-done-mapp
    Conference Papers | 2015
    Dr Melvin Teck Meng Chin
    Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 2015
    Dr Melvin Teck Meng Chin
    Schutze H; Chin M; Weller D; Suchy S; Harris M, 2015, 'Attitudes to cancer follow-up care in general practice - preliminary findings', in Attitudes to cancer follow-up care in general practice - preliminary findings, Health Science Alliance - Fourth Annual Scientific Symposium, Royal Womens Hospital, Randwick, Australia, presented at Health Science Alliance - Fourth Annual Scientific Symposium, Royal Womens Hospital, Randwick, Australia, 19 November 2015 - 19 November 2015, https://thehealthsciencealliance.org/sites/default/files/hsa/PPT/11_PM_Session3_3_Schutze_Breast%20and%20colorectal%20cancer.pdf
    Conference Posters | 2014
    Dr Melvin Teck Meng Chin
    Feeney K; Chin M; Ng S; Matos M; Mak G; McKendrick J, 2014, 'AFLIBERCEPT IN METASTATIC COLORECTAL CANCER (MCRC): DATA FROM CLINICAL TRIALS, LESSONS FROM CLINICAL PRACTICE', Melbourne, Vol. 10 Supplement S8, pp. 192 - 192, presented at COSA, Melbourne, 21 October 2014 - 24 October 2014, http://dx.doi.org/10.1111/ajco.12305
    Conference Presentations | 2014
    Dr Melvin Teck Meng Chin
    Harris M; Weller D; Ward R; Chin M; Meiser B; Crowley M, 2014, 'ATTITUDES TO CANCER FOLLOW-UP CARE IN GENERAL PRACTICE', Vol. 10, pp. 65 - 65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2013
    Dr Melvin Teck Meng Chin
    Pianta TJ; Chin M; Peake PW; Buckely NA; Pickering JW; Endre ZH, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', presented at 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology,, Brisbane, 09 September 2013 - 11 September 2013
    Conference Posters | 2013
    Dr Melvin Teck Meng Chin
    Pianta TJ; Peake P; Buckley NA; Pickering JW; Chin M; Endre ZH, (ed.), 2013, 'Plasma Cystatin C Should Not Be Used to Diagnose AKI after Cisplatin Therapy', Atlanta, GA, USA, Vol. 24, pp. 373A - 373A, presented at American Society of Nephrology Kidney Week 2013, Atlanta, GA, USA, 05 November 2013 - 10 November 2013
    Conference Papers | 2013
    Dr Melvin Teck Meng Chin
    Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Melvin Teck Meng Chin
    Lemech C; Fontela A; Arkenau H; Chin M; Li S; Liauw WS; Thomas D; De Souza P, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours', in Journal of clinical oncology - official journal of the American Society of Clinical Oncology, American Society of Clinical Oncology, New York, pp. e13585 - e13585, presented at ASCO Annual Meeting, Chicago, USA, 01 June 2012 - 05 June 2012, http://meeting.ascopubs.org/gca?gca=ascomtg%3B30%2F15_suppl%2Fe13585&allch=&submit=Go#abstr-1
    Conference Papers | 2011
    Dr Melvin Teck Meng Chin
    Herder GJ; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'Describing treatment, treatment outcomes, resource use and quality of life of advanced NSCLC patients – the Lung Cancer Economics and Outcomes Research (LUCEOR) studies.', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. 1404 - 1405, presented at Proceedings of the 14th World Conference on Lung Cancer, Amsterdam, http://dx.doi.org/10.1097/01.JTO.0000399290.73317.eb
    Conference Papers | 2009
    Dr Melvin Teck Meng Chin
    Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269009900396&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Grants

South Eastern Sydney Local Health District - The Inspiring Ideas Challenge -The 200K Challenge 2017 - Project Lead

Cancer Institute NSW- Innovations in Cancer Control Grant- Priority 4 Building on Innovations in Cancer Care, 2018- Co-investigator - Sharing follow-up care for patients with colorectal cancer

Cancer Australia Supporting People With Cancer Grant 2019 - Co-investigator- Co-designing patient engagement strategies to enhance safety in cancer services for culturally and linguistically diverse patients

National Health and Medical Research Council Ideas Grant 2019- Chief Investigator H - Enhancing safety and care quality for culturally and linguistically diverse cancer consumers: A consumer engagement approach.

Media